Clinical Assistant Professor
Carl Toborowsky, MS, MA, VMD, DACVIM (Cardiology), FASE is a clinical assistant professor of cardiology at the University of Illinois at Urbana-Champaign. He has a Master’s degree in Ecology, Evolution, and Systematics from the University of Missouri in St. Louis, and a Master’s degree in Primatology and Biological Anthropology from the University of Texas at Austin. He completed his veterinary degree at the University of Pennsylvania, a small animal rotating internship at Friendship Hospital for Animals in Washington, DC, followed by a cardiology specialty internship at BluePearl in Southfield, Michigan. He completed his cardiology residency at the University of Georgia, and is board-certified by the American College of Veterinary Internal Medicine in the specialty of Cardiology. Dr. Toborowsky recently became one of the only veterinary cardiologists who is also a Fellow of the American Society of Echocardiography (FASE).
His interests include interventional cardiology for both congenital and acquired cardiac diseases, novel therapies for the management of congestive heart failure, management of right-sided heart disease, pulmonary hypertension, mechanisms of overcoming diuretic resistance, and modulation of the renin-angiotensin-aldosterone system.
Outside of the office, Dr. T enjoys making up stories to tell his two unimpressed cats, playing music at least an hour every day, getting lost in new cities, cocktail making, trying new foods, and seeing live music.
Frontiers in Veterinary Cardiology: Novel Therapies and Innovations in Practice
Veterinary cardiology is advancing rapidly, with exciting breakthroughs in both medical and interventional therapies. This session will explore several cutting-edge developments, including the potential emerging role of rapamycin and other novel therapeutics on the horizon, such as SGLT2 inhibitors in the management of heart failure. We will also highlight ongoing innovations in interventional cardiology, such as occluding patent ductus arteriosus (PDA) using microvascular plugs, and hybrid procedures for both congenital and acquired heart disease. While each of these topics could warrant an in-depth lecture of its own, this session is designed to provide a broad overview and awareness of the therapies currently available and those under exploration, both in research and clinical practice. We hope this knowledge helps our referral community to identify future patients who may benefit from these advances and opens the door for continued collaborative care. The final portion of the session will be dedicated to open discussion and Q&A about any aspect of veterinary cardiology, from diagnosis to treatment and beyond.